Browsing by Author Jiang, Q.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 85  next >
Issue DateTitleAuthor(s)
2015ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPYJiang, Q.; Wang, H. B.; Mo, X. D.; Yu, L.; Huang, X. J.
2015ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPYJiang, Q.; Wang, H. B.; Mo, X. D.; Yu, L.; Huang, X. J.
2017ACHIEVING OPTIMAL RESPONSE AT 12 MONTHS IS ASSOCIATED WITH A BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE, LONGITUDINAL, SINGLE CENTER STUDYJiang, Q.; Wang, H.; Yu, L.; Milijkovic, D.; Huang, X.
2017ACHIEVING OPTIMAL RESPONSE AT 12 MONTHS IS ASSOCIATED WITH A BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE, LONGITUDINAL, SINGLE CENTER STUDYJiang, Q.; Wang, H.; Yu, L.; Milijkovic, D.; Huang, X.
2015ADAM28 OVEREXPRESSION REGULATED THROUGH PI3K/AKT PATHWAY IS ASSOCIATED WITH POOR PROGNOSIS IN DE NOVO ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAZhang, X. H.; Wang, C. C.; Wang, Q. M.; Feng, F. E.; Zhu, X. L.; Jiang, Q.; Yang, S. M.; Jiang, H.; Zhu, H. H.; Lu, J.; Zhao, T.; Xu, L. P.; Liu, K. Y.; Huang, X. J.
2015ADAM28 OVEREXPRESSION REGULATED THROUGH PI3K/AKT PATHWAY IS ASSOCIATED WITH POOR PROGNOSIS IN DE NOVO ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAZhang, X. H.; Wang, C. C.; Wang, Q. M.; Feng, F. E.; Zhu, X. L.; Jiang, Q.; Yang, S. M.; Jiang, H.; Zhu, H. H.; Lu, J.; Zhao, T.; Xu, L. P.; Liu, K. Y.; Huang, X. J.
2019Adherence to a healthy lifestyle and all-cause and cause-specific mortality in Chinese adults: A 10-year prospective study of 0.5 million peopleZhu, N.; Liu, F.; Lu, Y.; Ma, L.; Tang, A.; Zhang, S.; Jin, J.; Liu, J.; Tang, Z.; Chen, N.; Huang, Y.; Li, M.; Chen, J.; Meng, J.; Pan, R.; Jiang, Q.; Lan, J.; Liu, Y.; Wei, L.; Zhou, L.; Wang, N.C.P.; Meng, F.; Qin, Y.; Chen, Z.; Wang, S.; Wu, X.; Zhang, N.; Chen, X.; Zhou, W.; Luo, G.; Li, J.; Zhong, X.; Liu, J.; Sun, Q.; Lv, J.; Lv, J.; Lv, J.; Ge, P.; Ren, X.; Dong, C.; Zhang, H.; Mao, E.; Wang, X.; Wang, T.; Zang, X.; Zhang, D.; Zhou, G.; Li, L.; Feng, S.; Chang, L.; Fan, L.; Gao, Y.; He, T.; Sun, H.; He, P.; Hu, C.; Zhang, X.; Wu, H.; Clarke, R.; Yu, M.; Hu, R.; Wang, H.; Qian, Y.; Wang, C.; Xie, K.; Chen, L.; Zhang, Y.; Pan, D.; Gu, Q.; Collins, R.; Huang, Y.; Chen, B.; Yin, L.; Liu, H.; Fu, Z.; Xu, Q.; Xu, X.; Zhang, H.; Long, H.; Li, X.; Peto, R.; Zhang, L.; Qiu, Z.; Walters, R.; Avery, D.; Yu, C.; Boxall, R.; Bennett, D.; Chang, Y.; Gilbert, S.; Hacker, A.; Hill, M.; Holmes, M.; Iona, A.; Kartsonaki, C.; Kerosi, R.; Guo, Y.; Kong, L.; Kurmi, O.; Lancaster, G.; Lewington, S.; Lin, K.; McDonnell, J.; Millwood, I.; Nie, Q.; Radhakrishnan, J.; Ryder, P.; Bian, Z.; Sansome, S.; Schmidt, D.; Sherliker, P.; Sohoni, R.; Stevens, B.; Turnbull, I.; Wang, J.; Wang, L.; Wright, N.; Yang, X.; Han, Y.; Han, X.; Hou, C.; Pei, P.; Liu, C.; Pang, Z.; Gao, R.; Li, S.; Wang, S.; Liu, Y.; Du, R.; Yang, L.; Yang, L.; Zang, Y.; Cheng, L.; Tian, X.; Zhang, H.; Zhai, Y.; Ning, F.; Sun, X.; Li, F.; Lv, S.; Wang, J.; Chen, Y.; Chen, Y.; Hou, W.; Zeng, M.; Jiang, G.; Zhou, X.; Yang, L.; He, H.; Yu, B.; Li, Y.; Xu, Q.; Kang, Q.; Du, H.; Du, H.; Guo, Z.; Wang, D.; Hu, X.; Chen, J.; Fu, Y.; Fu, Z.; Wang, X.; Weng, M.; Guo, Z.; Wu, S.; Li, H.; Li, Y.; Fu, Z.; Wu, M.; Zhou, Y.; Zhou, J.; Tao, R.; Yang, J.; Su, J.; Zhang, J.; Hu, Y.
2014Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisisJiang, H.; Xu, L-P; Liu, D-H; Liu, K-Y; Chen, S-S; Jiang, B.; Jiang, Q.; Chen, H.; Chen, Y-H; Han, W.; Zhang, H.; Wang, Y.; Wang, J-Z; Wang, F-R; Qin, Y-Z; Lai, Y-Y; Huang, X-J
2016ARSENICTRIOXIDE REGULATES CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION BY TARGETING XPO1/SURVIVIN PATHWAY SIGNALLINGZhang, X. H.; Feng, R.; Zhang, J. M.; Yang, S. M.; Jiang, Q.; Jiang, H.; Lu, J.; Qin, Y. Z.; Xu, L. P.; Liu, K. Y.; Huang, X. J.
2016ARSENICTRIOXIDE REGULATES CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION BY TARGETING XPO1/SURVIVIN PATHWAY SIGNALLINGZhang, X. H.; Feng, R.; Zhang, J. M.; Yang, S. M.; Jiang, Q.; Jiang, H.; Lu, J.; Qin, Y. Z.; Xu, L. P.; Liu, K. Y.; Huang, X. J.
2016The assembly and function of the Annulate Lamellae pore complexes in Xenopus Egg extract and cultured mammalian cells.Lu, L. Q.; Ren, H.; Guo, L.; Jiang, Q.; Clarke, P. R.; Zhang, C.
2016The assembly and function of the Annulate Lamellae pore complexes in Xenopus Egg extract and cultured mammalian cells.Lu, L. Q.; Ren, H.; Guo, L.; Jiang, Q.; Clarke, P. R.; Zhang, C.
2017ASSESSMENT OF CHRONIC RENAL INJURY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE RECEIVING TYROSINE KINASE INHIBITORSJiang, Q.; Zuo, L.; Ren, X.; Huang, X.
2017ASSESSMENT OF CHRONIC RENAL INJURY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE RECEIVING TYROSINE KINASE INHIBITORSJiang, Q.; Zuo, L.; Ren, X.; Huang, X.
2013Autologous haematopoietic stem cell transplantation based on minimal residual disease (MRD) for patients with favourable- and intermediate-riskChen, H.; Liu, K.; Liu, D.; Xue, L.; Jiang, Q.; Jiang, B.; Chen, Y.; Zhu, H.; Zhen, Q.; Liu, Y.; Huang, X.
2019Black Phosphorous Quantum Dots Sandwiched Organic Solar CellsWang, Y.; Li, J.; Li, T.; Wang, J.; Liu, K.; Jiang, Q.; Tang, J.; Zhan, X.
2014CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemiaKong, Y.; Chang, Y-J; Liu, Y-R; Wang, Y-Z; Jiang, Q.; Jiang, H.; Qin, Y-Z; Hu, Y.; Lai, Y-Y; Duan, C-W; Hong, D-L; Huang, X-J
2019Clinical, molecular and cytogenetic characteristics of newly diagnosed adult acute myeloid patients with TP53 gene mutationChen, W.M.; Liu, Y.R.; Qin, Y.Z.; Liu, H.; Li, L.D.; Long, L.Y.; Lai, Y.Y.; Shi, H.X.; Zhao, X.S.; Jiang, H.; Jiang, Q.
2015THE COMBINATION OF ARSENIC TRIOXIDE AND IBRUTINIB INDUCES SYNERGISTIC APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA THAT IS POTENTLY ASSOCIATED WITH PI3K-AKT DOWN-REGULATIONZhang, X. H.; Feng, R.; Kong, Y.; Yang, S. M.; Jiang, Q.; Jiang, H.; Lv, M.; Xu, L. P.; Liu, K. Y.; Huang, X. J.
2015THE COMBINATION OF ARSENIC TRIOXIDE AND IBRUTINIB INDUCES SYNERGISTIC APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA THAT IS POTENTLY ASSOCIATED WITH PI3K-AKT DOWN-REGULATIONZhang, X. H.; Feng, R.; Kong, Y.; Yang, S. M.; Jiang, Q.; Jiang, H.; Lv, M.; Xu, L. P.; Liu, K. Y.; Huang, X. J.